Inactive Instrument

Coloplast A/S Stock Other OTC

Equities

CLPBY

US19624Y2000

Medical Equipment, Supplies & Distribution

Sales 2024 * 27.21B 3.91B Sales 2025 * 29.57B 4.25B Capitalization 194B 27.87B
Net income 2024 * 5.33B 765M Net income 2025 * 6.2B 890M EV / Sales 2024 * 7.83 x
Net Debt 2024 * 18.92B 2.72B Net Debt 2025 * 17.4B 2.5B EV / Sales 2025 * 7.15 x
P/E ratio 2024 *
36.2 x
P/E ratio 2025 *
31.2 x
Employees -
Yield 2024 *
2.37%
Yield 2025 *
2.59%
Free-Float 58.39%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 54 07-12-31
Director of Finance/CFO 52 05-12-31
Chairman 65 87-12-31
Members of the board TitleAgeSince
Director/Board Member 76 68-09-30
Director/Board Member 60 17-11-30
Chairman 65 87-12-31
More insiders
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.; - ostomy care products (36.8%): bags and equipment used following intestinal operations; - wound care and skincare products (11.9%): wound dressings, bandages, creams and gels; - voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).
Calendar
More about the company